Par Pharmaceuticals Archives - CDR

CEO succession at Endo

September 26, 2016 by Chain Drug Review Endo International, Par Pharmaceuticals, Paul Campanelli, Rajiv De Silva, Roger Kimmel Business, Pharmacy, Supplier News

DUBLIN, Ireland — Endo International plc has appointed Paul Campanelli, as president and chief executive officer, succeeding Rajiv De Silva, who is stepping down. Endo said Campanelli, who was president of its generic drugs and OTC business, takes the helm as president and CEO effective immediately. With the move, he will take De Silva’s spot

GPhA tabs Mylan’s Bresch to chair board

February 23, 2016 by Chain Drug Review Apotex, Chip Davis, generic drugs, Generic Pharmaceutical Association, GPhA, GPhA’s 2016 board of directors, Heather Bresch, Jeff Watson, mylan, Par Pharmaceuticals, Tony Pera Pharmacy, Supplier News

ORLANDO, Fla. — The Generic Pharmaceutical Association (GPhA) has elected Heather Bresch, chief executive officer of Mylan, to chair its board of directors this year. GPhA, which announced the move at its 2016 Annual Meeting here, also named other officers to its 2016 board and executive committee: Jeff Watson, president of global generics at Apotex,